White Bear Lake, MN, United States of America

Fatih M Uckun

This inventor holds 94 USPTO granted patents and 4 published patent applications, primarily in Cancer Treatment (CPC class C07D-). Top assignees: Parker Hughes Institute, Hughes Institute, Regents of the University of Minnesota. Active years: 1989-2023.

USPTO Granted Patents = 94 (Patent Applications = 4)

% Patents Active = 66.0

Average Co-Inventor Count = 2.0

ph-index = 20

Forward Citations = 1,368(Granted Patents)

Forward Citations (Not Self Cited) = 1,340(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Minneapolis, MN (US) (1989)
White Bear Leak, MN (US) (2002)
White Bear Lake, MN (US) (1996 - 2023)

Company Filing History:

68 out of 89

Parker Hughes Institute

Regents of the University of Minnesota

patents

4. 4 out of 7

Wayne Hughes Institute

patents

5. 2 out of 2

Ares Pharmaceuticals, LLC

patents

6. 1 out of 1,494

Rutgers, The State University of New Jersey

patents

7. 2 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1989-2023

Loading Chart...

Areas of Expertise:

Cinchona Alkaloids

Vanadium Compounds

HIV Treatment

JAK-3 Inhibitors

Cytotoxic Compounds

Aryl Phosphate Derivatives

Quinazolines

Microbicides

Cathepsin Inhibitors

Transgenic Models

Spermicidal Activity

Thiourea Compounds

94 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11649232 - Synthetic dimeric cinchona alkaloids against cancer (2023-05-16),

2. 11066421 - Synthetic cinchona alkaloids against cancer (2021-07-20),

3. 7186736 - NNI for treatment of multi-drug resistant HIV (2007-03-06),

4. 7144874 - Aryl phosphate derivatives of d4T having activity against resistant HIV strains (2006-12-05),

5. 7091351 - Vanadium compounds for treating cancer (2006-08-15),

6. 7038049 - Haloanilino quinazolines and therapeutic use thereof (2006-05-02),

7. 7037937 - Cytotoxic compounds (2006-05-02),

8. 6958359 - Vanadium compounds as anti-angiogenic agents (2005-10-25),

9. 6953875 - Transgenic zebra fish embryo model for hematopoiesis and lymphoproliferative disorders (2005-10-11),

10. 6933300 - JAK-3 inhibitors for treating allergic disorders (2005-08-23),

11. 6878388 - Vanadium compounds for treating proliferative cell disorders (2005-04-12),

12. 6864286 - Inhibitors of the EGF-receptor tyrosine kinase and methods for their use (2005-03-08),

13. 6825177 - Aryl phosphate derivatives of d4T with potent anti-viral activity (2004-11-30),

14. 6800649 - Method for inhibiting c-jun expression using JAK-3 inhibitors (2004-10-05),

15. 6797721 - Phorboxazole derivatives for treating cancer (2004-09-28),

Title: The Innovative Journey of Fatih M. Uckun

Introduction: Fatih M. Uckun is a renowned inventor based in White Bear Lake, MN (US) known for his groundbreaking contributions to the field of medicine and biotechnology.

Latest Patents: Fatih M. Uckun holds several patents in the medical and biotech sectors, focusing on novel treatments for various diseases and innovative medical devices.

Career Highlights: With a distinguished career spanning several decades, Fatih M. Uckun has held key positions in leading research institutions and universities, where he has spearheaded numerous research projects that have led to significant advancements in the medical field.

Collaborations: Throughout his career, Fatih M. Uckun has collaborated with top researchers, scientists, and medical professionals globally, fostering a culture of innovation and excellence in the projects he undertakes.

Conclusion: Fatih M. Uckun's relentless pursuit of innovation and his passion for improving healthcare have solidified his reputation as a pioneering inventor in the medical and biotech industries.